To earn CME related to this news article, click here. January 28, 2009 — Prolonged use, but not ever-use, of loop diuretics is linked to a higher fracture risk in postmenopausal women, according to ...
In a meta-analysis, researchers found no difference in all-cause mortality for intensive-care patients with fluid overload who were treated with loop diuretics, compared with those given a placebo or ...
Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...
Study finds no significant difference in hospitalization and death rates between patients who had a loop diuretic prescription at the time of peritoneal dialysis vs those who did not. Loop diuretic ...
Thirst outcomes were investigated among patients with stable heart failure (HF), due to the limited data available on this relationship and how it, along with fluid and sodium intake, influences ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — A treatment strategy of torsemide vs. furosemide did not improve long-term clinical outcomes for ...
Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual ...
Adding acetazolamide to conventional loop diuretics can improve the rate of decongestion in hospitalized acute decompensated heart failure (HF) patients better than diuretics alone, according to data ...
Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients with acute decompensated heart failure, according to late breaking research presented in a Hot Line ...
A new analysis suggests that finerenone (Kerendia), a newer heart failure medication, may help older adults rely less on high doses of water pills. The findings come from the large FINEARTS-HF ...
Please provide your email address to receive an email when new articles are posted on . Compared with placebo, Wegovy improved HF symptoms and physical limitations in patients with obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results